Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Stanley L Block"'
Autor:
Balpreet Matharu, Sophie Dimonaco, Laura Burleigh Macutkiewicz, Stanley L. Block, Steffen Wildum, Pedro A. Piedra, Neil Collinson, Barry Clinch, Jeffrey Baker
Publikováno v:
Pediatric Infectious Disease Journal. 39:700-705
BACKGROUND Baloxavir marboxil (baloxavir) is a novel, cap-dependent endonuclease inhibitor that has previously demonstrated efficacy in the treatment of influenza in adults and adolescents. We assessed the safety and efficacy of baloxavir in otherwis
Autor:
Stanley L. Block, Wendy Daly, Mary Tipton, Maria Lattanzi, Michele Pellegrini, Silvia Barbi, Pavitra Keshavan, Shelly Senders, Thembile Mzolo
Publikováno v:
Vaccine. 37:6171-6179
Background Vaccination strategies against bacterial meningitis vary across countries. In the United States, a single dose of quadrivalent meningococcal conjugate vaccine (MenACWY) is recommended at 11–12 years of age, with a booster dose approximat
Autor:
Jaime Alberto Restrepo, Rudiwilai Samakoses, Daron G. Ferris, Andrea Likos Krick, Jian Li Chu, Ole Erik Iversen, Alfred J. Saah, Archana Chatterjee, Jesper Mehlsen, Amita Joshi, Rituparna Das, Eduardo Lazcano-Ponce, Stanley L Block
Publikováno v:
Pediatrics. 140
OBJECTIVES: We describe the final 10-year data for the long-term follow-up study of the 4-valent human papillomavirus (4vHPV) vaccine in preadolescents and adolescents. METHODS: In the base study (V501-018), 1661 sexually inactive boys and girls rece
Autor:
Wendy Daly, Pavitra Keshavan, Stanley L. Block, Michele Pellegrini, Mary Tipton, Shelly Senders, Thembile Mzolo
Publikováno v:
Open Forum Infectious Diseases
Background Neisseria meningitidis serogroups A, B, C, W, and Y are a leading cause of bacterial meningitis and sepsis worldwide. Infants 75%, both in participants primed with MenACWY-CRM and MenACWY-D. Independent of quadrivalent meningococcal vaccin
Autor:
Bruce L. Innis, Mark M. Blatter, Varsha K. Jain, Michael E. Pichichero, Robert Jeanfreau, Roger Baxter, Walthère Dewé, Stanley L. Block
Publikováno v:
Pediatric Infectious Disease Journal. 29:924-930
Background: This study (NCT00383123) compared the immunogenicity and safety of 2 trivalent inactivated influenza vaccines: Fluarix [GlaxoSmithKline (study vaccine)] and Fluzone [Sanofi Pasteur (control vaccine)] in children 6 months to
Publikováno v:
Pediatrics. 141:260-260
Purpose: Antibiotic resistance may be problematic in the treatment of bacterial eye infections. Data from large, multi-center, multi-year surveillance studies are useful for tracking resistance to commonly used antibiotics. The Antibiotic Resistance
Publikováno v:
Clinical and Vaccine Immunology. 16:1810-1815
Neisseria meningitidis is a leading cause of bacterial meningitis in the United States, with the highest case fatality rates reported for individuals ≥15 years of age. This study compares the safety and immunogenicity of the Novartis Vaccines inves
Publikováno v:
The Journal of Infectious Diseases. 200:849-857
Background. This study assessed the safety, reactogenicity, and immunogenicity of an injectable cell culture-derived influenza vaccine (CCIV), compared with those of an injectable egg-based trivalent inactivated influenza vaccine (TIV). Methods. Adul
Autor:
Paul Wisman, Nicole Williams, Wilson Andrews, Jason W. Chien, Carla DeMuro, Todd Wolynn, Stanley L. Block, Sandy Lewis, Valerie Williams, Richard Schwartz, Seth L. Toback, Shelly Senders
Publikováno v:
Open Forum Infectious Diseases. 2
Autor:
Angela Ngai, Ginamarie Foglia, Jin Xu, Gary S. Marshall, Andrew W. Lee, Sheryl Flores, Maria Petrecz, Stanley L Block
Publikováno v:
Pediatrics. 137:188A-188A